India's investigational HPV pill, SHetA2, has sparked hope in the fight against cervical cancer. But experts caution it's ...
Screening for human papillomavirus (HPV) remains an effective way to find high-risk strains of HPV early. With self-sample ...
A new oral therapy, SHetA2, shows promise in stopping HPV from becoming cervical cancer, but larger human trials are still ...
Cervical cancer remains one of India's biggest public health challenges, claiming the lives of thousands of women every year ...
The HPV vaccine provides more than 90 per cent protection against cancers caused by the virus, but it does not eliminate the ...
The petition contends that the ongoing vaccination programme violates the constitutional rights of adolescent girls, ...
See more of our coverage in your search results. Add The New York Post on Google New research suggests the HPV vaccine is preventing cancer in men, as well as in women, but fewer boys than girls are ...
The development comes in the backdrop of a free nation-wide HPV vaccination campaign by India, launched on February 28, 2026.
The Delhi high court on Wednesday refused to stay the administration of the HPV vaccine Gardasil to 14-year-old girls under the Centre’s nationwide vaccination programme, saying there appeared to be “ ...
The Delhi High Court has declined to halt the Centre's HPV immunisation campaign, noting that data on 5.5 million ...
Delhi HC refused to pause India’s HPV vaccine drive but ordered agencies to address questions over safety, consent and adverse-event monitoring.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results